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Abstract
Purpose:  Ischemia--reperfusion  injury  is  one  of  the  consequences  of  tourniquet  application  for
extremity surgery.  The  aim  of  the  study  was  to  establish  the  effect  of  dexmedetomidine  on  the
acute lung  injury  following  lower  extremity  experimental  ischemia--reperfusion  model  in  rats.
Methods: Twenty-eight  Wistar-Albino  breed  Rats  were  recruited  after  Ethics  Committee
approval  and  allocated  into  4  groups,  each  with  7  subjects.  Group  1  (SHAM)  received  only
anesthesia.  Group  2  (IR)  had  experienced  3  h  of  ischemia  and  3  h  of  reperfusion  using  left
lower extremity  tourniquet  after  anesthesia  application.  Groups  3  (D-50)  and  4  (D-100)  had
undergone the  same  procedures  as  in  the  Group  2,  except  for  receiving  50  and  100  mg·kg−1,
respectively,  dexmedetomidine  intraperitoneally  1  h  before  the  tourniquet  release.  Blood  sam-
ples were  obtained  for  the  analysis  of  tumor  necrosing  factor-  and  interleukin-6.  Pulmonary
tissue samples  were  obtained  for  histological  analysis.
Results:  No  signiﬁcant  difference  regarding  blood  tumor  necrosing  factor-  and  interleukin-6
values was  found  among  the  groups,  whereas  pulmonary  tissue  injury  scores  revealed  signiﬁcant
difference.  Histological  scores  obtained  from  the  Group  2  were  signiﬁcantly  higher  from  those
in the  Groups  1,  3  and  4  with  p-values  0.001  for  each  comparison.  Moreover,  Group  1  scores
were found  to  be  signiﬁcantly  lower  than  those  in  the  Groups  3  and  4  with  p-values  0.001  and
0.011, respectively.  No  signiﬁcant  difference  was  observed  between  the  Groups  3  and  4.
Conclusion:  Dexmedetomidine  is  effective  in  reduction  of  the  experimental  ischemia--
reperfusion  induced  pulmonary  tissue  injury  in  rats,  formed  by  extremity  tourniquet  appli-a  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  This  is  an
cation.
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PALAVRAS-CHAVE
Experimental;
A  dexmedetomidina;
Lesão  de  reperfusão;
Lesão  pulmonar
aguda
Efeito  de  dexmedetomidina  sobre  lesão  pulmonar  aguda  em  modelo  experimental  de
isquemia-reperfusão
Resumo
Objetivo:  A  lesão  de  isquemia-reperfusão  é  uma  das  consequências  da  aplicac¸ão  do  torniquete
em cirurgias  de  extremidades.  O  objetivo  do  estudo  foi  determinar  o  efeito  de  dexmedetomidina
em lesão  pulmonar  aguda  após  modelo  experimental  de  isquemia-reperfusão  em  extremidade
inferior de  ratos.
Métodos:  Vinte  e  oito  ratos  albinos  Wistar  foram  recrutados  após  aprovac¸ão  do  Comitê  de
Ética e  alocados  em  quatro  grupos,  cada  um  com  sete  indivíduos.  O  Grupo  1  (Sham)  recebeu
apenas anestesia.  O  Grupo  2  (IR)  foi  submetido  a  3  horas  de  isquemia  e  3  horas  de  reperfusão
com o  uso  de  torniquete  em  extremidade  inferior  após  a  aplicac¸ão  da  anestesia.  Os  grupos
3 (D-50)  e  4  (D-100)  foram  submetidos  aos  mesmos  procedimentos  do  Grupo  2,  exceto  por
receberem  50  e  100  mg·kg−1 de  dexmedetomidina,  respectivamente,  por  via  intraperitoneal  1
hora antes  da  liberac¸ão  do  torniquete.  Amostras  de  sangue  foram  coletadas  para  análise  de  TNF-
 e  Interleucina-6  (IL-6).  Amostras  de  tecido  pulmonar  foram  coletadas  para  análise  histológica.
Resultados:  Não  houve  diferenc¸a  signiﬁcativa  quanto  aos  valores  sanguíneos  de  TNF-  e  IL-
6 entre  os  grupos,  enquanto  os  escores  de  lesão  em  tecidos  pulmonares  revelaram  diferenc¸a
signiﬁcativa.  Os  escores  histológicos  obtidos  no  Grupo  2  foram  signiﬁcativamente  maiores  que
os dos  grupos  1,  3  e  4,  com  valores-p  de  0,001  para  cada  comparac¸ão.  Além  disso,  os  escores
do Grupo  1  foram  signiﬁcativamente  menores  que  os  dos  grupos  3  e  4,  com  valores-p  de  0,001
e 0,011,  respectivamente.  Não  houve  diferenc¸a signiﬁcativa  entre  os  grupos  3  e  4.
Conclusão:  Dexmedetomidina  mostrou  eﬁcácia  na  reduc¸ão  de  lesão  em  tecido  pulmonar
induzida por  isquemia-reperfusão  experimental  em  ratos,  ocasionada  por  aplicac¸ão  de  torni-
quete em  extremidade.
©  2016  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um
artigo Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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essation  of  the  blood  ﬂow,  namely  tissue  ischemia,  and
eperfusion  after  a  period  of  time  are  the  main  patho-
hysiological  mechanisms  responsible  for  organ  damages
ollowing  some  clinical  conditions  like  organ  transplan-
ation,  cerebral  ischemia,  stroke,  myocardial  infarction,
hromboemboli,  cardiopulmonary  bypass  and  vascular  sur-
eries,  major  trauma  and  hemorrhagic  shock,  as  well  as
urgical  procedures  with  tourniquet  use.1,2 Ischemic  damage
s  mainly  the  result  of  the  necrosis  of  the  cells  due  to  oxy-
en  cessation;  oxygen  supply  during  ischemia  is  not  enough
o  meet  the  metabolic  needs  of  the  cells  and  this  condi-
ion  results  in  the  activation  of  the  anaerobic  metabolism.3
hen  the  tissue  blood  ﬂow  is  provided  again,  i.e.  reper-
usion  starts,  it  paradoxically  increases  the  local  tissue
amage,  together  with  an  inﬂammatory  response  resulting
n  distant  organ  damage.2,3 Many  inﬂammatory  agents  have
een  shown  to  be  responsible  for  this  damage,  namely
schemia--reperfusion  injury  (IRI).2
Cytokines  have  been  blamed  for  distant  organ  damage
f  IRI.4 Blood,  kidney  and  lung  tumor  necrosing  factor-
 (TNF-),  interleukin  (IL)  IL-1  and  IL-6  levels  have  been
ound  to  be  high  after  lower  extremity  ischemia.5 The
ediators  released  after  ischemia--reperfusion  (IR)  result  in
ocal  and  distant  organ  injuries  through  free  oxygen  radi-Please  cite  this  article  in  press  as:  Küc¸ükebe  ÖB,  et  al.  Effect  
ischemia--reperfusion  model.  Rev  Bras  Anestesiol.  2016.  http:/
als  and  leukocytes.6,7 Negative  immunoregulatory  effects
f  noradrenaline  have  been  demonstrated  in  the  forma-
ion  of  monocyte/macrophage  origin  mediators  (TNF-,
T
c
0L-1,  IL-6)  and  this  effect  was  linked  to  its  both    and  2
drenoceptors.8
Dexmedetomidine  is  a  strong  and  selective  2-adrenergic
gonist  that  is  an  active  d-isomer  of  medetomidine
nd  metabolized  in  the  liver.  It  has  been  approved  to
e  used  for  sedation  in  intensive  care  unit  and  pos-
esses  sedative  and  analgesic  characteristics.9,10 There  are
ew  studies  in  the  literature  regarding  anti-inﬂammatory
ffects  of  dexmedetomidine.11--16 Yagmurdur  et  al.14 have
emonstrated  dexmedetomidine  to  decrease  the  levels  of
alondialdehyde  and  hypoxanthine  (that  are  formed  after
R),  following  tourniquet  application  for  upper  extremity
urgery.  Although  it  has  been  shown  that  dexmedetomi-
ine  has  some  protective  effects  for  IRI  locally,  we  have
ot  encountered  a  study  regarding  its  effects  on  systemic
nﬂammatory  response  and  distant  organ  damage.
We  aimed  to  establish  the  effects  of  two  different
oses  of  dexmedetomidine  on  the  acute  lung  injury  fol-
owing  lower  extremity  experimental  IR  model  in  rats.
he  hypothesis  was  based  on  possible  protective  effects
f  dexmedetomidine  taking  into  consideration  its  anti-
nﬂammatory  effects.
ethodsof  dexmedetomidine  on  acute  lung  injury  in  experimental
/dx.doi.org/10.1016/j.bjane.2015.08.002
his  study  was  carried  out  in  Dokuz  Eylul  University  Medi-
al  Faculty  Multidisciplinary  Animal  Laboratory  between
1/01/2009  and  31/05/2009  after  the  obtainment  of  the
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Effect  of  dexmedetomidine  on  acute  lung  injury  
approval  of  Dokuz  Eylul  University  Experimental  Animal
Studies  Ethics  Committee, I˙zmir,  Turkey  (24/11/2008,  n◦
134,  Chairperson  Prof.  M.  Olguner).  Twenty-eight  adult
female  Wistar-Albino  breed  rats  weighting  250--340  g  were
used  for  the  study.  The  animals  were  provided  with  standard
pellet  food  and  water  and  were  kept  in  12-hour  cycles  of
light  and  dark  for  adaptation  before  the  commencement  of
the  study.  The  temperature  and  humidity  were  also  stan-
dardized.
The  rats  were  fasted  for  12  h  before  the  surgical  pro-
cedure  and  were  allowed  to  drink  water  only.  Each  rat
was  weighted  before  the  experiment  and  the  doses  of
dexmedetomidine  were  calculated.  They  were  randomly
allocated  into  one  of  the  4  groups  using  closed  envelope
method.  Group  1  (SHAM,  n  =  7)  received  only  anesthesia
with  blood  sample  obtainment  at  the  1st  hour  of  reper-
fusion  and  blood  and  tissue  sample  obtainment  at  the  end
of  the  reperfusion.  Group  2  (IR,  n  =  7)  had  experienced  3  h
of  ischemia  and  3  h  of  reperfusion  using  left  lower  extremity
tourniquet  after  anesthesia  application.  Blood  sample  was
obtained  at  the  1st  hour  of  reperfusion  and  at  the  end  of
the  reperfusion  blood  and  tissue  samples  were  obtained.
Group  3  (D-50,  n  =  7)  had  undergone  the  same  procedures  as
in  the  Group  2,  except  for  receiving  50  g/kg  dexmedeto-
midine  (Precedex,  Abbott  Laboratories  Ltd.  North  Chicago
ABD,  100  /mL)  intraperitoneally  1  hour  before  the  tourni-
quet  release.  Group  4  (D-100,  n  =  7)  had  undergone  the  same
procedures  as  in  the  Group  2,  except  for  receiving  100  g/kg
dexmedetomidine  intraperitoneally  1  h  before  the  tourni-
quet  release.  Again  the  blood  samples  were  obtained  at  the
1st  hours  of  the  reperfusion  with  blood  and  tissue  samples
at  the  end  of  the  reperfusion  for  the  Groups  3  and  4.
Anesthesia  was  performed  using  50  mg·kg−1 ketamine
(Pﬁzer  Pharma  GMBH,  Germany)  and  10  mg·kg−1 xylazine
hydrochloride  (Alfazine,  2%,  Egevet)  mixture  applied
intraperitoneally.  Ischemia  was  performed  using  elastic  ban-
dage  (1  cm  width  and  30  cm  length)  applied  to  the  inguinal
region  of  the  left  lower  extremity.  The  tourniquet  was
deﬂated  to  establish  reperfusion  after  the  certain  period
of  time.  The  environment  temperature  was  kept  stable  and
the  operation  table  was  heated  to  protect  the  rats  from
hypothermia  and  the  body  temperatures  were  kept  between
36.8 ◦C  and  37.5 ◦C.  The  rats  were  hydrated  with  3  mL/kg/h
isotonic  sodium  chloride  subcutaneously  throughout  the  IR
procedure  to  avoid  dehydration.  The  subjects  were  sacri-
ﬁced  after  the  obtainment  of  samples  of  blood  and  tissue.
The  procedure  durations  were  kept  equal  in  all  the  groups.
At  the  end  of  the  1st  hour  of  3-hour  reperfusion  period
1.5  mL  blood  was  drawn  from  the  tail  vein  of  the  rats  for  the
analysis  of  TNF- and  IL-6,  were  put  into  sterile  tube  with
ethylenediaminetetraacetic  acid  (EDTA)  and  centrifuged  for
10  min  with  1200  rpm  speed.  Plasma  of  the  blood  samples
were  separated  put  into  Eppendorf  tubes,  freezed  and  kept
at  70 ◦C  until  the  analysis  day.  The  rats  received  isotonic
sodium  chloride  intraperitoneally  equal  to  the  amount  lost
for  sampling.  At  the  end  of  the  reperfusion  thorax  was
opened  by  subdiaphragmatic  approach.  Blood  sample  for
TNF-  and  IL-6  analysis  was  obtained  in  2  mL  volume  directlyPlease  cite  this  article  in  press  as:  Küc¸ükebe  ÖB,  et  al.  Effect  
ischemia--reperfusion  model.  Rev  Bras  Anestesiol.  2016.  http:/
from  the  heart  and  was  kept  using  the  same  method  as  men-
tioned  above.  At  the  end  of  the  procedure  5  mL  of  10%  formol
was  slowly  applied  through  the  cardiac  apex  via  20G  needle
and  heart  and  lung  bed  were  excised  after  the  sacriﬁcation.
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 section  from  the  middle  zone  of  the  right  lung  and  the  left
ung  totally  were  put  into  10%  formol  and  kept  ﬁxed  for  at
east  24  h.
nalysis  of  inﬂammatory  mediators
he  analysis  of  inﬂammatory  mediators  (TNF- vs.  IL-6)
as  performed  via  Enzyme-Linked  Immunosorbent  Assay
ELISA).  Absorbent  values  were  read  at  450  nm  in  the  ELISA
evice  (Organon  Technica  Microwell  System  Reader  230S).
he  results  were  expressed  in  pg/mL.
istopathological  analysis
ulmonary  tissues  obtained  from  the  subjects  were  stained
sing  hematoxylin-eosin  method  and  examined  by  light
icroscope  (Olympus  BH-2)  under  200× magniﬁcation.  Six
andom  regions  were  selected  from  each  sample  and  0--4
oint  scoring  were  made  taking  into  account  histopatho-
ogical  ﬁndings  like  alveolar  and  interstitial  hemorrhage,
lveolar  and  interstitial  neutrophile  inﬁltration,  edema  and
telectasis.  Scoring  was  made  according  to  the  injured  area
roportion  as  0:  no  injury,  1:  <25%  injury,  2:  25--50%  injury,
:  50--75%  injury,  4:  diffuse  injury.
tatistical  analysis
he  data  obtained  was  evaluated  using  SPSS  11.0  software
Statistical  Package  for  the  Social  Sciences,  Chicago,  Illi-
ois).  Kruskall  Wallis  and  Chi-square  tests  were  used  for
omparison  of  the  groups.  Mann--Whitney  U  test  was  used
or  comparison  of  the  groups  separately  and  Bonferroni  cor-
ection  was  used  when  needed.  p-Values  less  than  0.05  were
onsidered  statistically  signiﬁcant.
esults
his  study  was  completed  with  28  rats,  each  group  contain-
ng  seven.  The  time  interval  for  the  study  was  the  same  as
ndicated  in  Methods  section  (Fig.  1).
Table  1  represents  TNF- and  IL-6  values  and  histological
cores  of  the  pulmonary  tissue.  Intergroup  analysis  revealed
o  statistically  signiﬁcant  difference  regarding  TNF- and
L-6  values  neither  in  the  1st,  nor  in  the  3rd  hours  of  reper-
usion.
Statistical  analysis  of  the  pulmonary  injury  histologi-
al  scores  was  made  using  median  values  of  the  scores
btained  from  6 microscopic  areas  examined.  There  was  sta-
istically  signiﬁcant  difference  among  the  groups  regarding
ulmonary  injury  scores  (p  =  0.001).  There  was  observed  dif-
use  injury  (score  4)  in  all  the  specimens  of  the  Group  2.
istological  scores  obtained  from  the  Group  2  were  signiﬁ-
antly  different  from  the  Groups  1,  3  and  4  with  p-values  of
.001  for  each  comparison.  Moreover,  Group  1  scores  were
ound  to  be  signiﬁcantly  different  from  the  Groups  3  and  4
ith  p-values  of  0.001  and  0.011,  respectively.  No  signiﬁcantof  dexmedetomidine  on  acute  lung  injury  in  experimental
/dx.doi.org/10.1016/j.bjane.2015.08.002
ifference  was  observed  between  the  Groups  3  and  4.
In  the  microscopical  examination;  samples  from  the
roup  1  demonstrated  normal  alveolar  sequence,  perialveo-
ar  structures  and  cells,  and  normal  interstitial  areas  (Fig.  2).
Please  cite  this  article  in  press  as:  Küc¸ükebe  ÖB,  et  al.  Effect  
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Figure  1  Schematic  representa
Figure  2  Group  1,  normal  structure  of  ventilated  pulmonary
tissue.
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amples  from  the  Group  2  showed  interstitial  and  intraalve-
lar  neutrophile  inﬁltration,  hemorrhage,  interalveolar
eptal  thickening,  interstitial  edema,  diffuse  emphysema-
ous  areas  and  congestion.  Large  magniﬁcation  revealed
ostly  atelectatic  areas  and  areas  with  capillary  stasis
ith  decreased  ventilation,  collapsed  alveoli,  nonfunctional
arenchymal  areas,  dense  parenchymal  neutrophile  and
acrophage  inﬁltration  in  these  regions,  diffuse  intraalve-
lar  hemorrhage  in  the  capillary  stasis  areas  and  patchy
brosis  areas  together  with  sparse  normally  ventilated  ﬁelds
Figs.  3  and  4).  Samples  from  the  Group  3  demonstrated  dif-
use  interstitial  neutrophile  inﬁltration;  interalveolar  septal
hickening,  atelectasis,  congestion,  hemorrhage  and  emphy-
ema  less  than  in  the  Group  2.  Normal  pulmonary  tissue  was
bserved  at  the  neighboring  areas,  despite  mild  parenchy-of  dexmedetomidine  on  acute  lung  injury  in  experimental
/dx.doi.org/10.1016/j.bjane.2015.08.002
al  enlargement  and  neutrophile  inﬁltration.  Some  regions
evealed  normal  pulmonary  tissue  together  with  intense
arenchymal  hemorrhage,  emphysematous  areas  and  peri-
ronchial  inﬁltrations  (Fig.  5).  Samples  from  the  Group
ARTICLE IN PRESS+ModelBJANE-705; No. of Pages 8
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Table  1  TNF-  and  IL-6  values  and  histological  scores.
Group  1
(SHAM)
n =  7
Group  2
(IR)
n =  7
Group  3
(D  50)
n =  7
Group  4
(D  100)
n =  7
p
TNF-˛  (pg/mL)
Reperfusion  1  h 9.40
(7.40--11.50)
10.10
(9.10--25.30)
9.70
(8.30--10.90)
9.70
(7.70--10.60)
0.55
Reperfusion  3  h  9.30
(8.20--10.90)
9.80
(9.30--22.90)
10.20
(8.70--11.80)
9.00
(8.90--12.10)
0.26
IL-6 (pg/mL)
Reperfusion  1  h  27.10
(21.60--41.30)
17.30
(13.20--52.60)
19.00
(15.80--58.00)
25.20
(20.00--48.90)
0.11
Reperfusion  3  h  32.70
(21.60--64.70)
61.20
(17.40--120.30)
24.40
(14.00--91.80)
31.80
(21.40--47.70)
0.83
Histological  score  0.5b
(0.0--1.0)
4.0a
(4.0--4.0)
2.5
(2.0--3.0)
2.0
(0.5--3.5)
0.001
a Signiﬁcant difference in the Group 2 compared with the Groups 1, 3 and 4, p < 0.05.
b Signiﬁcant difference in the Group 1 compared with the Groups 3 and 4, p < 0.05.
The values are represented in median (minimum--maximum).
Figure  3  Group  2,  alveolar  structure  has  lost  its  pattern  (↑), Figure  4  Group  2,  dense  neutrophile  inﬁltration,  parenchy-mal enlargement,  non-ventilated  pulmonary  areas  (  )  and
atelectatic  areas  (A).emphysematous  changes  (A),  parenchymal  inﬂammatory  cell
inﬁltration  (P˙I).
4  demonstrated  mild  interstitial  neutrophile  inﬁltration,
interalveolar  septal  thickening,  atelectasis,  congestion  and
hemorrhage  to  a  much  lesser  extent  than  in  the  Group  2.
Some  regions  revealed  completely  normal  pulmonary  tissue
(Fig.  6).
Discussion
The  main  outcome  of  the  study  was  that,  dexmedetomi-
dine  decreased  histological  injury  scores  related  to  IR  in  rats
experiencing  ischemia  and  reperfusion,  that  was  generated
by  extremity  tourniquet  application.  Although  there  were
not  observed  differences  among  the  groups  as  regards  blood
inﬂammatory  mediators  TNF- and  IL-6,  there  were  signif-Please  cite  this  article  in  press  as:  Küc¸ükebe  ÖB,  et  al.  Effect  of  dexmedetomidine  on  acute  lung  injury  in  experimental
ischemia--reperfusion  model.  Rev  Bras  Anestesiol.  2016.  http://dx.doi.org/10.1016/j.bjane.2015.08.002
icant  difference  regarding  histological  appearances  of  the
tissues.  Histological  scores  of  the  Group  2  were  found  to  be
high,  indicating  the  effects  of  the  IR  injury  to  the  pulmonary
Figure  5  Group  3,  mild  parenchymal  enlargement  and  neu-
trophile inﬁltration  (*)  together  with  normal  neighboring
pulmonary  tissue  structure.
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Figure  6  Group  4,  mild  inﬂammatory  inﬁltration  and  thick-
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oned interalveolar  septum  (*)  together  with  normal  pulmonary
issue.
issue.  Groups  3  and  4  demonstrated  lower  injury  scores,
ndicating  protective  effect  of  dexmedetomidine  against  IRI.
Although  some  authors  offer  multiple  ligation  method
nstead  of  tourniquet  application  because  of  the  concern
f  venous  and  lymphatic  obstruction,  muscle,  nerve  dam-
ge  after  prolonged  mechanical  compression,17 tourniquet
ethod  is  non-invasive  and  seems  to  be  more  practical  in
he  clinical  application.7,18
Different  ischemia  and  reperfusion  times  had  been
sed  for  IR  creation  in  the  literature.  We  had  taken  into
ccount  resistance  of  the  tissue  against  ischemia  in  our
tudy.  For  instance,  prominent  morphological  changes  in
he  muscle  tissue  appear  after  2  h  of  ischemia  and  so,
he  studies  dealing  with  muscle  IRI  had  used  long  ischemia
eriods.19,20 Important  correlation  between  ischemia  period
nd  ischemic  injury  was  found.21 Taking  into  account
hat  there  had  been  demonstrated  irreversible  histological
njury20 and  diffuse  neutrophile  inﬁltration18 in  the  muscle
issue  after  3  h  of  ischemia  period  in  the  studies  dealing  with
RI  in  the  muscle,  we  had  chosen  our  ischemia  period  to  be
 h  in  the  study.
Reperfusion  period  also  was  found  to  be  an  important  fac-
or  in  the  formation  of  local  and  distant  effects  of  IR.2,7,19
asin  et  al.7 had  used  different  reperfusion  times  after
 h  ischemia  and  found  positive  correlation  between  reper-
usion  period  and  distant  organ  dysfunctions.  They  had  also
emonstrated  histological  changes  after  the  3  h  of  reper-
usion,  that  were  not  apparent  in  the  ﬁrst  2  h.  On  account
f  this  we  had  chosen  the  reperfusion  time  to  be  3  h.  Promi-
ent  histological  changes,  as  diffuse  neutrophile  inﬁltration,
lveolar  sequence  distortion,  edema,  in  the  pulmonary  tis-
ue  of  the  IR  group  had  supported  our  choice.  These  ﬁndings
ere  coherent  with  the  studies  that  used  the  same  time
eriods.7,18
TNF- was  shown  to  play  an  important  role  in  the
athogenesis  of  Systemic  Inﬂammatory  Response  Syndrome
SIRS)  and  Multiple  Organ  Failure  (MOF).5,22,23 Similar  mech-
nisms  were  suggested  in  the  local  and  distant  effects  of
RI  and  studies  conducted  had  shown  TNF- to  play  role  in
he  organ  damage  pathogenesis.3,7 Similarly,  IL-6  also  wasPlease  cite  this  article  in  press  as:  Küc¸ükebe  ÖB,  et  al.  Effect  
ischemia--reperfusion  model.  Rev  Bras  Anestesiol.  2016.  http:/
hown  to  play  role  in  complex  inﬂammatory  reaction  related
o  trauma,  shock  and  infection.24 Positive  correlation  was
emonstrated  between  plasma  IL-6  concentrations  and
a
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agnitude  of  soft  tissue  damage.24 IL-6  levels  were  shown  to
ncrease  in  correlation  with  TNF- in  the  studies  dealing  with
ower  extremity  IR  models.5,6 Yasin  et  al.7 had  suggested
hat  IR  related  inﬂammatory  response  can  be  shown  with
erum  TNF- and  IL-6  levels  and  that  there  is  positive  corre-
ation  between  this  increase  and  distant  organ  injuries.  They
ad  evaluated  blood  TNF- and  IL-6  levels  at  the  1st,  2nd  and
rd  hours  of  reperfusion  after  3-hour  ischemia  period.  TNF-
 was  found  to  increase  signiﬁcantly  at  the  end  of  the  1st
our  and  return  to  control  values  at  the  2nd  hour;  whereas
L-6  was  found  to  increase  progressively  after  the  1st  hour
f  reperfusion  with  peak  at  the  end  of  the  3rd  hour.  Hence,
e  had  evaluated  blood  TNF- and  IL-6  levels  both  at  the
nd  of  the  1st  and  3rd  hours.
There  have  been  conducted  many  clinical  and  experi-
ental  studies  with  dexmedetomidine  as  it  shows  analgesic,
nxiolytic  and  sedative  properties  alltogether.25,26 More-
ver,  it  has  been  shown  that  dexmedetomidine  possesses
ntiinﬂammatory  properties  in  the  studies  investigating
ts  effects  in  ischemic  and  toxic  inﬂammatory  models.11
aniguchi  et  al.11 have  demonstrated  that  dexmedetomi-
ine  alleviates  lung  injury  and  decreases  mortality  rates  by
ecreasing  TNF- and  IL-6  levels  and  neutrophile  inﬁltra-
ion  in  the  alveolar  walls  in  the  experimental  endotoxemic
eptic  shock  model.  Shen  et  al.27 have  investigated  TNF-
nd  IL-6  levels  in  lung  injury  caused  by  experimental  intesti-
al  IRI  model  and  demonstrated  decreased  production  of
hese  cytokines  in  pulmonary  tissue  after  dexmedetomidine
dministration.
Dexmedetomidine  has  been  used  via  intraperitoneal
oute  before28 or  during12--14 IR  in  rat  IR  models.  Although
exmedetomidine’s  protective  effects  had  been  shown
egardless  of  its  time  of  administration,  there  are
o  studies  in  the  literature  comparing  its  application
eriods.  Furthermore,  some  studies  investigating  the  effects
f  intraperitoneally  administered  dexmedetomidine  have
hown  that,  IR  periods  were  not  longer  than  the  elimina-
ion  time  of  dexmedetomidine.13,28 Taking  into  consideration
hat  the  main  culprit  in  the  formation  of  lung  injury  is  reper-
usion  process,  and  that  TNF- levels  begin  to  rise  near
he  end  of  the  ischemia  with  peak  levels  at  the  1st  hour
f  reperfusion,7 it  was  relevant  to  apply  dexmedetomidine
 hour  before  the  reperfusion.
We  have  not  come  across  certain  dose  intervals
f  dexmedetomidine  for  its  antiinﬂammatory  effects  in
he  literature.  The  dose  for  dexmedetomidine,  applied
ntraperitoneally,  was  decided  to  be  100  g/kg,  a  highest
ose  safely  applied  in  the  current  literature,16,28 and  the
econd  dose  was  decided  to  be  50  g/kg,  to  evaluate  its
ossible  dose  dependent  effects.
Despite  similar  IR  periods  in  the  studies  regarding  rat
ulmonary  IRI  after  extremity  tourniquet  application,  differ-
nt  results  regarding  TNF- levels  have  been  observed.5,18,29
eekamp  et  al.5 have  demonstrated  that  TNF- levels  were
ot  detectable  in  the  blood  throughout  the  4-hour  ischemia
eriod,  but  started  to  rise  at  the  1st  hour  of  reperfusion
ith  decline  after  the  2nd  hour.  In  addition,  IL-6  levels
tarted  to  rise  at  the  30th  minute  with  peak  at  the  end
f  the  4th  hour.  Yassin  et  al.7 have  stated  that,  TNF-of  dexmedetomidine  on  acute  lung  injury  in  experimental
/dx.doi.org/10.1016/j.bjane.2015.08.002
nd  IL-6  levels  reach  their  peak  levels  at  the  1st  and  3rd
ours  of  reperfusion,  respectively;  TNF- levels  drop  below
etectable  levels  after  the  2nd  hour  of  reperfusion  and
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IL-6  reach  detectable  levels  in  plasma  from  the  1st  hour  of
reperfusion.
Duru  et  al.,18 Harkin  et  al.,30 Gaines  et  al.31 have  used
similar  IR  models  and  time  periods;  despite  they  have
demonstrated  histopathological  changes  due  to  IR  injury,
they  could  not  observe  changes  in  TNF- levels.  Similarly,
Welbourn  et  al.29 could  not  observe  TNF- level  changes
after  reperfusion;  they  have  concluded  that  TNF- had
role  in  the  IRI  pathogenesis  as  histopathological  changes
decreased  with  the  application  of  anti-TNF  serum.  We  have
also  found  no  differences  in  the  TNF- and  IL-6  levels  in  the
dexmedetomidine  applied  groups,  compared  to  SHAM  group,
despite  signiﬁcant  histopathological  differences.  This  condi-
tion  may  be  attributed  to  insufﬁcient  number  of  subjects.
Duru  et  al.18 have  stated  that,  the  reason  they  could  not  have
demonstrated  cytokine  level  changes  was  that  they  might
have  spared  TNF- peak  levels,  as  they  obtained  blood  sam-
ples  at  the  end  of  the  2nd  hour  of  reperfusion.  Gaines  et  al.31
attributed  this  to  the  blood  sample  insufﬁciency.  Welbourn
et  al.29 have  proposed  that  TNF- can  stay  in  the  tissue  after
production  in  the  pulmonary  macrophages  and  so  could  not
always  be  detected  in  the  blood;  it  can  mediate  pulmonary
tissue  injury  activating  endothelium  locally.
IRI  generated  by  the  tourniquet  model  was  histopatho-
logically  demonstrated  in  this  study.  The  changes  in  the
IR  group  were  signiﬁcant  compared  to  the  SHAM  and  both
dexmedetomidine  groups,  and  this  veriﬁed  that  the  model
was  appropriately  conducted.  Signiﬁcant  differences  in  the
ﬁndings  in  the  dexmedetomidine  groups  compared  to  the
IR  group  was  interpreted  as  that  dexmedetomidine  had
decreased  pulmonary  injury.
Although  histopathological  scores  between  the  groups
with  dexmedetomidine  50  and  100  g/kg  were  not  signif-
icantly  different,  some  normal  pulmonary  tissue  areas  in
the  microscopical  examination  in  the  D  100  group  suggested
that  the  drug  might  have  acted  in  dose  dependent  manner.
Studies  with  larger  sample  sizes  with  different  doses,  admin-
istration  time  and  routes  may  be  conducted  to  evaluate  this
effect.
No  limitations  for  the  study  were  encountered.
In  conclusion,  in  our  experimental  study  of  lower
extremity  tourniquet  induced  IR  model,  dexmedetomidine
was  effective  in  preventing  the  IR  induced  lung  injury.
Histopathological  and  IL-6  level  differences  between  the
two  groups  with  different  doses  of  dexmedetomidine,
although  not  statistically  signiﬁcant,  suggests  to  conduct
studies  with  larger  sample  sizes  to  evaluate  the  effects  of
different  doses.
Implication statement
This  experimental  study  demonstrates  the  ability  of
dexmedetomidine  to  reduce  experimental  ischemia--
reperfusion  related  injury  in  rats.  Controlled  trials  can  be
conducted  in  human  to  observe  the  clinical  signiﬁcance  of
this  effect.Please  cite  this  article  in  press  as:  Küc¸ükebe  ÖB,  et  al.  Effect  
ischemia--reperfusion  model.  Rev  Bras  Anestesiol.  2016.  http:/
Conﬂicts of interest
The  authors  declare  no  conﬂicts  of  interest.
2 PRESS
7
eferences
1. Cerra FB, Lajos TZ, Montes M, et al. Hemorrhagic infarction:
a reperfusion injury following prolonged myocardial ischemic
anoxia. Surgery. 1975;78:95--104.
2. Welbourn CR, Goldman G, Paterson IS, et al. Pathophysiology of
ischaemia reperfusion injury: central role of the neutrophil. Br
J Surg. 1991;78:651--5.
3. Grace PA. Ischaemia--reperfusion injury. Br J Surg.
1994;81:637--47.
4. Vilcek J. The cytokines: an overview. In: Thomson AW, editor.
The Cytokine Handbook, vol. 1, 4th ed. London: Elsevier Science
Academic Press; 2003. p. 3--18.
5. Seekamp A, Mulligan MS, Till GO, et al. Requirements
for tumor necrosis factor-alpha and interleukin-1 in limb
ischemia/reperfusion injury and associated lung injury. Am J
Pathol. 1993;143:453--63.
6. Seekamp A, Till GO, Mulligan MS, et al. Role of selectins in local
and remote tissue injury following ischemia and reperfusion.
Am J Pathol. 1994;144:592--8.
7. Yassin MM, Barros D’Sa AA, Parks G, et al. Lower limb
ischemia--reperfusion injury triggers a systemic inﬂamma-
tory response and multiple organ dysfunction. World J Surg.
2002;26:115--21.
8. Maes M, Lin A, Kenis G, et al. The effects of noradrenaline and
alpha-2 adrenoceptor agents on the production of monocytic
products. Psychiatry Res. 2000;96:245--53.
9. Venn RM, Bryant A, Hall GM, et al. Preliminary UK experience
of dexmedetomidine a novel agent for postoperative sedation
in the intensive care unit. Anaesthesia. 1999;54:1136--42.
0. Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs.
2000;59:263--70.
1. Taniguchi T, Kidani Y, Kanakura H, et al. Effects of
dexmedetomidine on mortality rate and inﬂammatory
responses to endotoxin-induced shock in rats. Crit Care Med.
2004;32:1322--6.
2. Jolkkonen J, Puurunen K, Koistinaho J, et al. Neuroprotection
by the alpha2-adrenoceptor agonist, dexmedetomidine, in rat
focal cerebral ischemia. Eur J Pharmacol. 1999;372:31--6.
3. Eser O, Fidan H, Sahin O, et al. The inﬂuence of dexmedeto-
midine on ischemic rat hippocampus. Brain Res. 2008;1218:
250--6.
4. Yagmurdur H, Ozcan N, Dokumaci F, et al. Dexmedetomi-
dine reduces the ischemia--reperfusion injury markers during
upper extremity surgery with tourniquet. J Hand Surg Am.
2008;33:941--7.
5. Yang CL, Tsai PS, Huang CJ. Effects of dexmedetomidine on
regulating pulmonary inﬂammation in a rat model of ventilator-
induced lung injury. Acta Anaesthesiol Taiwan. 2008;46:
151--9.
6. Kocoglu H, Ozturk H, Ozturk H, et al. Effect of dexmedeto-
midine on ischemia--reperfusion injury in rat kidney: a
histopathologic study. Ren Fail. 2009;31:70--4.
7. Tassiopoulos AP, Carlin RE, Gao Y, et al. Role of nitric
oxide and tumor necrosis factor on lung injury caused by
ischemia/reperfusion of the lower extremities. J Vasc Surg.
1997;26:647--56.
8. Duru S, Koca U, Öztekin S, et al. Antithrombin III pre-
treatment reduces neutrophil recruitment into the lung and
skeletal muscle tissues in the rat model of bilateral lower
limb and reperfusion: a pilot study. Acta Anaesthesiol Scand.
2005;49:1142--8.
9. Khalil AA, Aziz FA, Hall JC. Reperfusion injury. Plast Reconstrof  dexmedetomidine  on  acute  lung  injury  in  experimental
/dx.doi.org/10.1016/j.bjane.2015.08.002
Surg. 2006;117:1024--33.
0. Blaisdell FW. The pathophysiology of skeletal muscle ischemia
and the reperfusion syndrome: a review. Cardiovasc Surg.
2002;10:620--30.
 IN+ModelB
8
2
2
2
2
2
2
2
2
2
3ARTICLEJANE-705; No. of Pages 8
 
1. Petrasek PF, Homer-Vanniasinkam S, Walker PM. Determi-
nants of ischemic injury to skeletal muscle. J Vasc Surg.
1994;19:623--31.
2. Seal JB, Gewertz BL. Vascular dysfunction in ischemia--
reperfusion injury. Ann Vasc Surg. 2005;19:572--84.
3. Yao YM, Sheng ZY, Yu Y, et al. The potential etiologic role of
tumor necrosis factor in mediating multiple organ dysfunction
in rats following intestinal ischemia--reperfusion injury. Resus-
citation. 1995;29:157--68.
4. Roumen RM, Hendriks T, van der Ven-Jonge KJ, et al. Cytokine
patterns in patients after major vascular surgery, hemorrhagic
shock, and severe blunt trauma. Relation with subsequent adult
respiratory distress syndrome and multiple organ failure. Ann
Surg. 1993;218:769--76.
5. Koroglu A, Demirbilek S, Teksan H, et al. Sedative,
haemodynamic and respiratory effects of dexmedetomidine inPlease  cite  this  article  in  press  as:  Küc¸ükebe  ÖB,  et  al.  Effect  
ischemia--reperfusion  model.  Rev  Bras  Anestesiol.  2016.  http:/
children undergoing magnetic resonance imaging examination:
preliminary results. Br J Anaesth. 2005;94:821--4.
6. Arain SR, Ruehlow RM, Uhrich TD, et al. The efﬁcacy
of dexmedetomidine versus morphine for postoperative
3 PRESS
Ö.B.  Küc¸ükebe  et  al.
analgesia after major inpatient surgery. Anesth Analg. 2004;98:
153--8.
7. Shen J, Fu G, Jiang L, et al. Effect of dexmedeto-
midine pretreatment on lung injury following intestinal
ischemia--reperfusion. Exp Ther Med. 2013;6:1359--64.
8. Engelhard K, Werner C, Eberspacher E, et al. The effect
of the alpha 2-agonist dexmedetomidine and the N-methyl-
d-aspartate antagonist S(+)-ketamine on the expression
of apoptosis-regulating proteins after incomplete cerebral
ischemia and reperfusion in rats. Anesth Analg. 2003;96:
524--31.
9. Welbourn R, Goldman G, O’Riordain M, et al. Role for tumor
necrosis factor as mediator of lung injury following lower torso
ischemia. J Appl Physiol. 1991;70:2645--9.
0. Harkin DW, Barros D’Sa AA, McCallion K, et al. Ischemic pre-
conditioning before lower limb ischemia--reperfusion protectsof  dexmedetomidine  on  acute  lung  injury  in  experimental
/dx.doi.org/10.1016/j.bjane.2015.08.002
against acute lung injury. J Vasc Surg. 2002;35:1264--73.
1. Gaines GC, Welborn MB 3rd, Moldawer LL, et al. Attenuation
of skeletal muscle ischemia/reperfusion injury by inhibition of
tumor necrosis factor. J Vasc Surg. 1999;29:370--6.
